While generics save billions, some patients experience real side effects after switching. Learn why bioequivalence doesn't always mean identical results, especially for thyroid, seizure, and blood-thinner medications.
Read more
The FDA uses dissolution testing to ensure generic drugs release medicine at the same rate as brand-name versions, replacing human trials with reliable lab tests. This process guarantees safety, effectiveness, and affordability.
Read more
Combination NTI drugs offer powerful treatment for complex conditions but face major barriers to generic availability. With no approved fixed-dose combinations in the U.S., patients face higher costs, increased monitoring, and greater risk of adverse events after generic switches.
Read more